Takeda Completes Acquisition of Nimbus Therapeutics' TYK2 Program Subsidiary

OSAKA, Japan & CAMBRIDGE, Mass.--(BUSINESS WIRE)--Takeda (TSE:4502/NYSE:TAK) today announced that it has completed an acquisition of all shares of Nimbus La

Related Keywords

Japan ,Osaka ,United States ,Ramona Sequeira ,Megan Ostrower ,Christopher Oreilly ,Nimbus Lakshmi Inc ,Exchange Commission ,Nimbus Therapeutics ,Takeda Pharmaceutical Company Limited ,United States Federal Trade Commission ,Program Subsidiary ,Nimbus Lakshmi ,Nimbus Therapeutic ,News Global ,Completes Acquisition ,Rare Genetics ,Plasma Derived Therapies ,Annual Report ,